No Data
No Data
Express News | Denali Capital Acquisition Corp - Extends Business Combination Deadline to April 11, 2025
Express News | Denali Capital Acquisition Corp. Extends Deadline To Complete Combination From July 11, 2024 To April 11, 2025
Express News | Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination
Non-Opioid Pain Therapy-Focused Semnur Pharmaceuticals Strikes $2B SPAC Deal For NASDAQ Debut
Semnur Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company (NASDAQ:SCLX), and Denali Capital Acquisition Corp. (NASDAQ:DECA), a special purpose acquisition company, signed a lett
Express News | Scilex Shares Are Trading Higher After the Company's Semnur Pharmaceuticals Subsidiary Signed a Letter of Intent for a Proposed Business Combination With Denali Capital Acquisition Corp
Scilex Holding-Unit Semnur, Denali Capital Acquisition Eye Potential Combination
Scilex Holding's subsidiary and Denali Capital Acquisition signed a letter of intent for a proposed business combination.
No Data
Jaguar8 : Hahahaha I will erase this in my memory
TrytosaveabitOP Jaguar8: You know it’s a new deal with new company? The deal with LONGEVITY out and now it’s SCILEX/SEMNUR!
Jaguar8 TrytosaveabitOP: Yes and will take 9 months more with no assurance so maybe I’ll look at it next year
TrytosaveabitOP Jaguar8: Right! Unless it drops below 2.00? Then I may start scaling in?